Q3 2024 · 13F-HR
Pivotal bioVenture Partners Investment Advisor LLCholdings as filed
Filed 2024-11-13 · accession 0001012975-24-000471
$168.5M
Reported value
11
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92243G108 | PCVX | VAXCYTE INC | $73.1M | 43.4% | 639,539 | Common | SHARED |
| 45790W108 | — | INOZYME PHARMA INC | $23.5M | 14.0% | 4,494,851 | Common | SHARED |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $19.7M | 11.7% | 2,120,508 | Common | SHARED |
| H5870P102 | OCS | OCULIS HOLDING AG | $19.6M | 11.6% | 1,595,918 | Common | SHARED |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $11.0M | 6.54% | 650,695 | Common | SHARED |
| 09077V100 | BIOA | BIOAGE LABS INC | $11.0M | 6.51% | 527,647 | Common | SHARED |
| 30223G102 | EXAIEUR | EXSCIENTIA PLC | $3.8M | 2.23% | 770,500 | Common | SHARED |
| 75120L100 | — | RALLYBIO CORP | $2.8M | 1.67% | 2,404,644 | Common | SHARED |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $1.9M | 1.13% | 560,595 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.2M | 0.73% | 1,891,467 | Common | SHARED |
| 449778109 | IOBTQ | IO BIOTECH INC | $907,407 | 0.54% | 864,197 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.